Cytokinetics Stock Price - CYTK

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last: $ 11.15 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Cytokinetics Inc CYTK NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.035 -0.31% 11.145 11.57 11.00 11.18 11.18 20:00:00
Bid Price Ask Price Spread Spread % News
8.52 15.95 7.43 46.58% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,190 245,797 $ 11.26 $ 2,767,239 433,062 5.75 - 14.94
Last Trade Time Type Quantity Stock Price Currency
16:37:16 average 129 $ 11.145 USD

Cytokinetics Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 653.98M 58.68M $ -106.29M -1.95 - 57.38M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -6.00 2.20%

more financials information »

Cytokinetics News

Loading Messages....

Latest CYTK Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYTK Price Data

Period † Open High Low VWAP Avg. Daily Vol [m] Change %
1 Week11.5811.8910.676911.1127318k-0.435-3.76%
1 Month12.913.4910.676912.1134437k-1.755-13.60%
3 Months11.1814.9410.676912.6547426k-0.035-0.31%
6 Months8.814.947.0111.2039448k2.34526.65%
1 Year7.6114.945.759.3440458k3.53546.45%
3 Years9.2917.25.7510.5416449k1.85519.97%
5 Years3.3317.23.159.6113421k7.815234.68%

Cytokinetics Description

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatment for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.